SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001140361-22-041917 from HCM Acquisition Corp (CIK 0001845368)

HCM Acquisition Corp (CIK 0001845368)
Date: Nov. 16, 2022 · CIK: 0001845368 · Accession: 0001140361-22-041917

AI Filing Summary & Sentiment

File numbers found in text: 001-41241

Date
November 16, 2022
Author
Not clearly detected
Form
CORRESP
Company
HCM Acquisition Corp (CIK 0001845368)

Letter

King & Spalding LLP

1180 Peachtree Street N.E.

Atlanta, GA 30309-3521

www.kslaw.com

Kevin E. Manz

kmanz@kslaw.com

T 212.556.2133

F 212.556.2222

November 16, 2022

Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street, NE

Washington, DC 20549

Attn:

Ruairi Regan

Jeffrey Gabor

Re:

HCM Acquisition Corp

Preliminary Proxy Statement on Schedule 14A

Filed November 9, 2022

File No. 001-41241

Ladies and Gentlemen:

This letter responds to the comment letter (the “Comment Letter”) of the staff (the “Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”),

dated November 15, 2022, to Mr. James Bond, President and Chief Financial Officer of HCM Acquisition Corp (“HCM” or the “Company”) regarding the Preliminary Proxy Statement on Schedule 14A filed on November 9, 2022 (the “Preliminary Proxy”).

This letter sets forth each comment of the Staff in the Comment Letter and, following the comment, sets forth the Company’s response.

Preliminary Proxy Statement on Schedule 14A

General

1.

With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

November 16, 2022

Page Two

The Company respectfully acknowledges the Staff’s comment and submits that HCM Investor Holdings, LLC (the “HCM Sponsor”) is a Delaware limited liability company with a principal place of business in Connecticut. Further, the managing member of the HCM Sponsor is Shawn Matthews, a U.S. person and resident of Connecticut. Additionally, to the best of the Company’s knowledge, all directors and officers of HCM are U.S. persons. As such the Company advises the Staff that the HCM Sponsor is not, is not controlled by, and does not have substantial ties with a non-U.S. person.

November 16, 2022

Page Three

The Company and its management acknowledge they are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the Staff.

Please do not hesitate to contact Kevin E. Manz, Esq. at (212) 556-2133 if you have any questions regarding this letter.

Very truly yours,
/s/ King & Spalding LLP

Show Raw Text
CORRESP
1
filename1.htm

                King & Spalding LLP

                1180 Peachtree Street N.E.

                Atlanta, GA 30309-3521

                www.kslaw.com

                Kevin E. Manz

                kmanz@kslaw.com

                T   212.556.2133

                F   212.556.2222

            November 16, 2022

    Securities and Exchange Commission

    Division of Corporation Finance

    Office of Real Estate & Construction

    100 F Street, NE

    Washington, DC 20549

              Attn:

              Ruairi Regan

                Jeffrey Gabor

          Re:

            HCM Acquisition Corp

              Preliminary Proxy Statement on Schedule 14A

              Filed November 9, 2022

              File No. 001-41241

    Ladies and Gentlemen:

    This letter responds to the comment letter (the “Comment Letter”) of the staff (the “Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”),

      dated November 15, 2022, to Mr. James Bond, President and Chief Financial Officer of HCM Acquisition Corp (“HCM” or the “Company”) regarding the Preliminary Proxy Statement on Schedule 14A filed on November 9, 2022 (the “Preliminary
        Proxy”).

    This letter sets forth each comment of the Staff in the Comment Letter and, following the comment, sets forth the Company’s response.

    Preliminary Proxy Statement on Schedule 14A

    General

              1.

              With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact
                could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be
                subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an
                initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and
                require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire
                worthless.

     November 16, 2022

      Page Two

    The Company respectfully acknowledges the Staff’s comment and submits that HCM Investor Holdings, LLC (the “HCM Sponsor”) is a Delaware limited liability company with a principal place of business in Connecticut.
      Further, the managing member of the HCM Sponsor is Shawn Matthews, a U.S. person and resident of Connecticut. Additionally, to the best of the Company’s knowledge, all directors and officers of HCM are U.S. persons. As such the Company advises the
      Staff that the HCM Sponsor is not, is not controlled by, and does not have substantial ties with a non-U.S. person.

       November 16, 2022

        Page Three

    The Company and its management acknowledge they are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the Staff.

    Please do not hesitate to contact Kevin E. Manz, Esq. at (212) 556-2133 if you have any questions regarding this letter.

    Very truly yours,

    /s/ King & Spalding LLP

      King & Spalding LLP

    Kevin E. Manz

    Partner